Kairos Pharma, LTD.

Pharmaceutical company · Los Angeles, California, United States · NYSE: KAPA

Kairos Pharma, LTD. is a pharmaceutical company headquartered in Los Angeles, California, United States. Its shares trade on NYSE under the ticker KAPA. It has reported private securities offerings to the US SEC, most recently $3.5 million sold in a notice filed in 2025.

Profile compiled from public records. Is this your company? Request a correction or update

Kairos Pharma at a glance

Typepharmaceutical company

HeadquartersLos Angeles, California, United States

Stock listingNYSE: KAPA

SEC industryPharmaceutical Preparations

SEC CIK1962011

What does Kairos Pharma do?

Private fundraising reported to the SEC

2 Form D notices; the most recent reported $3.5 million sold (2025).

Frequently asked questions about Kairos Pharma

Where is Kairos Pharma headquartered?

Kairos Pharma, LTD. is headquartered in Los Angeles, California, United States.

What does Kairos Pharma do?

Kairos Pharma, LTD. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.

Is Kairos Pharma a public company?

Yes. Kairos Pharma, LTD. trades on NYSE under the ticker KAPA.

Similar companies

Niagen Bioscience, Inc.Los Angeles, California, United States
Puma Biotechnology, Inc.Los Angeles, California, United States
Capricor IncLos Angeles, California, United States
Immix Biopharma, Inc.Los Angeles, California, United States
Lunai Bioworks Inc.Los Angeles, California, United States
Avenzoar Pharmaceuticals, Inc.Los Angeles, California, United States
Targeted Medical Pharma, Inc.Los Angeles, California, United States
Pelage Pharmaceuticals, Inc.Los Angeles, California, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences